PLX7486

Plexxikon MOA PLX7486

Targeted Indication Status Sites link to clinicaltrials.gov

NTRK or
CSF-1R-driven
tumors

Phase 1/1b

Los Angeles, CA
Charleston, SC
Scottsdale, AZ
Boston, MA
Baltimore, MD

NCT01804530

These compounds and/or uses are investigational and have not been approved by the FDA or any other regulatory authority for the uses under investigation. Image above depicts proposed targeted pathway of the investigational agent(s) in the targeted indication.

Bapat AA et al. Nat Rev Cancer. 2011; 11(10); 695-707.
Data on file.